DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation

Haoran Cui1, Qin Wang2, Zhenchuan Lei3

  • 1Department of Cell Biology and Key Laboratory of Experimental Teratology, Ministry of Education, Shandong University School of Medicine, Jinan, Shandong, China.

Abstract

Insights

The study reveals that DTL degrades the tumor suppressor PDCD4 (Programmed cell death 4), promoting cancer cell proliferation and migration. This finding highlights DTL as a potential therapeutic target in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The ubiquitin E3 ligase CUL4A is implicated in cancer development.
  • DTL, a CUL4-DDB1 associated factor (DCAF), may play a role in oncogenesis.
  • Programmed cell death 4 (PDCD4) is a tumor suppressor involved in apoptosis and tumor progression.

Purpose of the Study:

  • To investigate the role of DTL in cancer development.
  • To identify PDCD4 as a potential substrate of DTL.
  • To elucidate the mechanism by which DTL influences cancer cell behavior.

Main Methods:

  • Affinity-purification mass spectrometry and Co-immunoprecipitation (Co-IP) to identify and verify protein interactions.
  • Quantitative real-time PCR to assess mRNA levels.
  • Lentivirus-mediated gene manipulation (overexpression and knockdown) to study gene function.
  • In vitro ubiquitination assays to determine degradation mechanisms.
  • Transwell, wound healing, Matrigel, MTT, and colony formation assays to evaluate cell migration, invasion, and proliferation.
  • Tumorigenesis assays in nude mice.

Main Results:

  • PDCD4 was identified as a substrate of DTL, with DTL accelerating PDCD4 degradation via ubiquitination.
  • DTL overexpression decreased PDCD4 protein levels and enhanced cancer cell proliferation, migration, and invasion.
  • DTL was significantly upregulated in cancer tissues, correlating with lower patient survival rates.
  • Silencing PDCD4 reversed the DTL-induced cancer cell phenotypes.

Conclusions:

  • DTL promotes cancer development by degrading the tumor suppressor PDCD4.
  • DTL enhances cancer cell motility and proliferation.
  • DTL represents a potential therapeutic target for cancer treatment.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K
Regulated Protein Degradation02:58

Regulated Protein Degradation

3.1K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
14.2K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K